Jana Hohmann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jana Hohmann has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Anneleen Goedgebeur
Department of Radiation Oncology, UZ Leuven, Herestraat 49, Leuven, Flanders, 3000, BELGIUM
1 shared publication - Aude Geeraerts
Radiation protection Dosimetry and Calibration Expert Group, SCK-CEN, Boeretang 200, Mol, Flanders, 2400, BELGIUM
1 shared publication - Beate Timmermann
Department of Particle Therapy, University Hospital Essen, West German Proton Therapy Centre Essen (WPE), West German Cancer Center (WTZ), German Cancer Consortium (DKTK), Essen, Germany
1 shared publication - Carina Behrends
Department of Physics, TU Dortmund University, 44221 Dortmund, Germany
1 shared publication - Christian Bäumer
West German Proton Therapy Centre Essen Essen Germany
1 shared publication - Claus Maximilian Bäcker
West German Proton Therapy Centre Essen, D-45122 Essen, Germany
1 shared publication
Latest Publications
- Open Access
- 30 December 2025
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 71 (1) , 015019
Validation of Monte Carlo simulations with measurement data for fetal dose assessment in proton therapy for breast cancer
Objective . This study aims to validate a Monte Carlo model for fetal dose estimation in the complex secondary field of pencil beam scanning (PBS) proton therapy for breast cancer, one of the most common cancers occurring during pregnancy. Approach . A TOPAS/GEANT4 Monte Carlo simulation environment based on an IBA ProteusOne beam model was developed, reflecting the experimental setup of a breast irradiation using a pregnant anthropomorphic phantom. Experimental doses were acquired with thermoluminescent dosimeters for protons and gammas, and bubble detectors (BDs) for neutrons. Simulated doses were scored at the same positions using three hadronic physics models: BIC_HP, BIC_AllHP, and BERT_HP. Experimental doses were corrected for detector energy response using simulation-derived energy spectra. Main results . Agreement between simulation and measurement varied depending on hadronic model, scoring volume size, and correcting for BD energy response. Two physics models conservatively estimated fetal neutron doses within the combined measurement and simulation uncertainties, with BIC_AllHP showing the closest agreement. Combined proton and gamma doses were accurately reproduced for all models for inserts 2–6, but were underestimated for insert 1, likely due to dose gradients and modeling limitations near the treatment field. The total simulated fetal dose equivalent at the fundus height was 5.17 mSv. This value is substantially lower than doses reported for photon-based therapies, remains well below the 100 mSv threshold for deterministic effects, and is within range of the public 1 mSv dose limit. Significance . The results demonstrate that, within the tested experimental framework, the TOPAS/GEANT4 Monte Carlo model is suitable for fetal dose estimation in PBS proton therapy for breast cancer. In this setting, calculated fetal doses were substantially lower than those reported for photon-based radiotherapy. The validated framework provides a practical basis for treatment planning optimization and risk assessment and can be extended to other clinical scenarios following similar validation.
- 30 December 2025
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 71 (1) , 015019
Open AccessValidation of Monte Carlo simulations with measurement data for fetal dose assessment in proton therapy for breast cancer
Objective . This study aims to validate a Monte Carlo model for fetal dose estimation in the complex secondary field of pencil beam scanning (PBS) proton therapy for breast cancer, one of the most common cancers occurring during pregnancy. Approach . A TOPAS/GEANT4 Monte Carlo simulation environment based on an IBA ProteusOne beam model was developed, reflecting the experimental setup of a breast irradiation using a pregnant anthropomorphic phantom. Experimental doses were acquired with thermoluminescent dosimeters for protons and gammas, and bubble detectors (BDs) for neutrons. Simulated doses were scored at the same positions using three hadronic physics models: BIC_HP, BIC_AllHP, and BERT_HP. Experimental doses were corrected for detector energy response using simulation-derived energy spectra. Main results . Agreement between simulation and measurement varied depending on hadronic model, scoring volume size, and correcting for BD energy response. Two physics models conservatively estimated fetal neutron doses within the combined measurement and simulation uncertainties, with BIC_AllHP showing the closest agreement. Combined proton and gamma doses were accurately reproduced for all models for inserts 2–6, but were underestimated for insert 1, likely due to dose gradients and modeling limitations near the treatment field. The total simulated fetal dose equivalent at the fundus height was 5.17 mSv. This value is substantially lower than doses reported for photon-based therapies, remains well below the 100 mSv threshold for deterministic effects, and is within range of the public 1 mSv dose limit. Significance . The results demonstrate that, within the tested experimental framework, the TOPAS/GEANT4 Monte Carlo model is suitable for fetal dose estimation in PBS proton therapy for breast cancer. In this setting, calculated fetal doses were substantially lower than those reported for photon-based radiotherapy. The validated framework provides a practical basis for treatment planning optimization and risk assessment and can be extended to other clinical scenarios following similar validation.
- Open Access
- 29 November 2022
- Published by MDPI AG in Instruments
- Vol. 6 (4) , 80
Measuring the Beam Energy in Proton Therapy Facilities Using ATLAS IBL Pixel Detectors
The accurate measurement of the beam range in the frame of quality assurance (QA) is a requirement for clinical use of a proton therapy machine. Conventionally used detectors mostly estimate the range by measuring the depth dose distribution of the protons. In this paper, we use pixel detectors designed for individual particle tracking in the high-radiation environment of the ATLAS experiment at LHC. The detector measures the deposited energy in the sensor for individual protons. Due to the limited dynamic energy range of the readout chip, several ways to measure the proton energy or range are examined. A staircase phantom is placed on the detector to perform an energy calibration relative to the NIST PSTAR stopping power database. In addition, track length measurements are performed using the detector aligned parallel with the beam axis to investigate the Linear Energy Transfer (LET) per pixel along the trajectory of individual protons. In this proof-of-principle study, we show that this radiation hardness detector can successfully be used to determine the initial proton energy for protons impinging on the sensor with an energy below 44 MeV after the range shifters. It becomes clear that an improvement of the energy resolution of the readout chip is required for clinical use.
- 29 November 2022
- Published by MDPI AG in Instruments
- Vol. 6 (4) , 80
Open AccessMeasuring the Beam Energy in Proton Therapy Facilities Using ATLAS IBL Pixel Detectors
The accurate measurement of the beam range in the frame of quality assurance (QA) is a requirement for clinical use of a proton therapy machine. Conventionally used detectors mostly estimate the range by measuring the depth dose distribution of the protons. In this paper, we use pixel detectors designed for individual particle tracking in the high-radiation environment of the ATLAS experiment at LHC. The detector measures the deposited energy in the sensor for individual protons. Due to the limited dynamic energy range of the readout chip, several ways to measure the proton energy or range are examined. A staircase phantom is placed on the detector to perform an energy calibration relative to the NIST PSTAR stopping power database. In addition, track length measurements are performed using the detector aligned parallel with the beam axis to investigate the Linear Energy Transfer (LET) per pixel along the trajectory of individual protons. In this proof-of-principle study, we show that this radiation hardness detector can successfully be used to determine the initial proton energy for protons impinging on the sensor with an energy below 44 MeV after the range shifters. It becomes clear that an improvement of the energy resolution of the readout chip is required for clinical use.